Djokovic bets on a COVID cure as he quests for tennis history
Djokovic holds a majority stake in a Danish biotech firm aiming to develop a treatment to counter COVID-19, the company's CEO told Reuters.
QuantBioRes boss Ivan Loncarevic, who described himself as an entrepreneur, said the tennis player's acquisition of the 80% stake was made in June 2020.
The company is developing a peptide, which inhibits the coronavirus from infecting the human cell, expects to launch clinical trials in Britain this summer.
The CEO said the company had about a dozen researchers working in Denmark, Australia and Slovenia.
I hope they're successful!